AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Semafor’s Take on Lilly Shows AI Discovery Has Become a Board-Level Capital Allocation Decision
Semafor’s coverage of Lilly’s latest AI licensing deal captures a turning point in pharma strategy: AI discovery is now being managed as a core investment category, not a skunkworks experiment. That reframing puts more pressure on executives to tie AI partnerships to pipeline outcomes and return on R&D spend.
CNBC’s Lilly-Insilico coverage shows Wall Street is treating AI drug discovery as a capital allocation priority
CNBC’s reporting on Lilly’s multibillion-dollar Insilico deal highlights how AI drug discovery is becoming a board-level capital allocation topic, not just an R&D experiment. The size and visibility of the transaction suggest public-market investors now see AI partnerships as meaningful indicators of pharmaceutical strategy.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.